Laura Brandt

Assistant Professor

Main Affiliation

Psychology

Building

North Academic Center (NAC)

Office

7/317

Laura Brandt Headshot

Laura Brandt

Profile

Dr. Brandt’s professional training unfolded through theoretical and clinical psychology training at the University of Vienna, a doctoral degree in Applied Medical Science at the Medical University of Vienna and postdoctoral training in transfer and implementation science. Simultaneously, her research has evolved from observational/descriptive accounts of the psychiatric burden as well as gender-specific aspects of addiction to exploring new and improved intervention approaches and simultaneously developing implementation strategies.

Currently, Dr. Brandt is working with the National Institute on Drug Abuse Clinical Trials Network and a team of data scientists to empirically identify and validate surrogate treatment outcomes for opioid use disorder. Using her background in implementation research, she hopes to establish cross-national standards for measuring opioid use disorder treatment response that are useful for researchers and acceptable to patients, clinicians, policy makers and regulatory agencies. Another line of her research involves evaluating implementation and intervention outcomes of overdose prevention practices.

Education

Ph.D. in Applied Medical Science – Mental Health Medical University of Vienna, 2015

M.A. in Psychology University of Vienna, 2011

Courses Taught

V6563: Research & Program Evaluation

Publications

For a complete list of peer-reviewed papers please see: https://www.ncbi.nlm.nih.gov/myncbi/laura.brandt.1/bibliography/public/

Brandt, L., Hu, M.-C., Liu, Y., Castillo, F., Odom, G., Balise, R., Feaster, D.J., Nunes, E.V., Luo, S.X. (in press). Risk of Experiencing an Overdose Event for Patients Undergoing Treatment with Medication for Opioid Use Disorder. American Journal of Psychiatry

Brandt, L., Anthonipillai, N., Lopez-Castro, T., Melara, R., & Espinosa, A. (accepted). Substance use trajectories among urban college students: Associations with symptoms of stress, anxiety, and depression before and during COVID-19. Journal of American College Health. DOI: 10.1080/07448481.2022.2089844.

Brandt, L., Campbell, A.N.C., Jones, J.D., Martinez, S., Neale, J., Parkin, S., Brown, C., Strang, J., & Comer, S.D. (2021). Emotional reactions of trained overdose responders who use opioids following intervention in an overdose event. Substance Abuse. DOI: 10.1080/08897077.2021.1975870

Brandt, L., Yanagida, T., Campbell, A.N.C., Jones, J.D., Schultes, M.-T., Martinez, S., & Comer, S.D. (2021). Multi-Informant Implementation and Intervention Outcomes of Opioid Overdose Education and Naloxone Distribution in New York City. Global Implementation Research and Applications. DOI: 10.1007/s43477-021-00021-4.

Brandt, L., Levin, F.R., & Kraigher, D. (2021). Impulsive Personality Traits Mediate the Relationship between Attention-Deficit/Hyperactivity Disorder Symptoms and Psychiatric Comorbidity among Patients with Severe Alcohol Use Disorder. Journal of Dual Diagnosis, 17(3),  193-206. DOI: 10.1080/15504263.2021.1944711.

Brandt, L., Chao, T., Comer, S., & Levin, F.R. (2021). How can we optimally channel therapeutic optimism to advance pharmacotherapy research on cocaine use disorder? Addiction. DOI: 10.1111/add.15423.

Brandt, L., Chao, T., Comer, S., & Levin, F.R. (2020). Pharmacotherapeutic Strategies for Treating Cocaine Use Disorder – What Do We Have to Offer? Addiction. DOI: 10.1111/add.15242

Brandt, L., Jones, J. D., Martinez, S., Manubay, J. M., Mogali, S., Ramey, T., Levin, F. R., & Comer, S. D. (2020). Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder. Drug and Alcohol Dependence, 208, 107859. DOI: 10.1016/j.drugalcdep.2020.107859

Brandt, L., Schultes, M.-T., Yanagida, T., Maier, G., Kollmayer, M., & Spiel, C. (2019). Differential associations of health literacy with Austrian adolescents’ tobacco and alcohol use behaviors. Public Health, 174, 74-82. DOI: 10.1016/j.puhe.2019.05.033

Silbernagl, M., Yanagida, T., Slamanig, R., Fischer, G., Brandt, L. (2019). Comorbidity patterns among patients with opioid use disorder and problem gambling: ADHD status predicts class membership. Journal of Dual Diagnosis, 15(3), 147-158. DOI: 10.1080/15504263.2019.1590672.

Silbernagl, M., Slamanig, R., Fischer, G., Brandt, L. (2018). Hepatitis C infection and psychiatric burden in two imprisoned cohorts: young offenders and opioid-maintained prisoners. Health Policy, 122, 1392-1402. DOI: 10.1016/j.healthpol.2018.10.005

Brandt, L., Schober, B., Schultes, M.-T., Somoza, V., & Spiel, C. (2018). Supporting Third Mission activities at Universities: Deans' opinions and recommendations. Zeitschrift für Hochschulentwicklung [Journal for Higher Education Development], 13(2). DOI: 10.3217/zfhe-13-02/02

Kollmayer, M., Pfaffel, A., Schober, B., & Brandt, L. (2018). Gender-fair language reduces male bias in mental representations. Frontiers, online publication. DOI: 10.3389/fpsyg.2018.00985

Brandt, L. & Finnegan, L. (2017). Neonatal Abstinence Syndrome – Where are we, and where do we go from here?. Current Opinion in Psychiatry, 30(4), 268-274. DOI: 10.1097/YCO.0000000000000334

Brandt, L., Silbernagl, M., & Fischer, G. (2017). Auswirkungen von neutralen Zigarettenverpackungen (plain packaging) auf das Rauchverhalten. [The effect of plain packaging on smoking behaviour]. Suchtmedizin, 19(2), 55-62.

Brandt, L. & Fischer, G. (2017). Adult Attention deficit/hyperactivity disorder is associated with gambling severity and psychiatric co-morbidity amongst treatment-seeking problem gamblers. Journal of Attention Disorders, 23(12) 1383–1395. DOI: 10.1177/1087054717690232

Brandt, L., Swoboda, P., Fischer, G., & Unger, A. (2016). Monitoring neonatal abstinence syndrome in buprenorphine-exposed IVF twins: a case study. Substance Abuse, 37(4), 501-506. DOI: 10.1080/08897077.2016.1184738.

Brandt, L., Unger, A., Moser, L., Fischer, G., & Jagsch, R. (2016). Opioid maintenance treatment – A call for a joint European quality care approach. European Addiction Research, 22, 36-51. DOI: 10.1159/000432395. (Awarded with the 2016 EMCDDA scientific award, Category: Demand-reduction research http://www.emcdda.europa.eu/activities/scientific-award-shortlist-2016)

Brandt, L., & Fischer, G. (2015). Tobacco cessation – a guide for clinicians. European Urology Focus, 1, 47-49. DOI: 10.1016/j.euf.2014.10.004

Brandt, L., Pintzinger, N.M., & Tran, U.S. (2015). Abnormalities in automatic processing of illness-related stimuli in self-rated alexithymia. Plos One, 10(6): e0129905. DOI: 10.1371/journal.pone.0129905.

Brandt, L., Fischberger, S., Unger, A., Jagsch, R., Moser, L., & Fischer, G. (2015). Neonatal abstinence syndrome after intrauterine opioid exposure: Standards, cost-effectiveness of treatment and maternal rights. Heroin Addiction and Related Clinical Problems, 17(2-3), 35-44.​